Analyst Ratings for Stemline Therapeutics (STML) [Neutrals]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
5/5/2020 | H.C. Wainwright | Raghuram Selvaraju | Downgrade | Neutral (Buy) |
12.50 (N/A) |
12.11 (11.83) |
-2.31% | Details |
5/5/2020 | Ladenburg Thalmann | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
12.11 (11.83) |
-2.31% | Details |